Press Releases
CRF Health Scoops 2018 TrialConsent® Hat Trick as CARE...
CRF Health, the leading provider of patient-centered eSource for the life sciences industry, announced that its TrialConsent® electronic informed consent solution has been shortlisted for...
Press Releases
Biotech uses New Technology to fight Cardiovascular Diseases
Despite significant technological advances in technology, cardiovascular diseases (CVDs) remain the number one cause of death globally. CVDs are a group of disorders of both...
Press Releases
Alma Lasers Inc., receives new FDA clearance soprano ICE...
Alma Lasers, a subsidiary of Sisram Medical Ltd , the leading global innovator of laser light-based, radio frequency and ultrasound solutions for the aesthetic and...
Press Releases
Study claims the Importance of familiarizing the risks and...
On average, 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from...
Press Releases
FDA Approval for Allegra’s filing for supplemental new drug...
Allergan plc, a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to quality medicines,...
Press Releases
AbbVie and Voyager Therapeutics collaborates for Neurodegenerative Diseases
AbbVie , a global biopharmaceutical company, and Voyager Therapeutics, Inc. , a clinical-stage gene therapy company announced that they have entered into an exclusive strategic...
Press Releases
Astrazeneca’s Imfinzi for unresectable Stage III non-small cell lung...
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US FDA has approved Imfinzi for the treatment of patients with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.